INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P908. A total of 5 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,790,000 | – | 200,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 189 | $905,000 | 0.06% |
| GROUP ONE TRADING, L.P. | 109,500 | $5,246,000 | 0.02% |
| SIMPLEX TRADING, LLC | 354 | $1,696,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |